VR Logo

Unrated

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.60 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.60 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 58.94 1.02 2.31 3.70 5.53 32.70 59.54 -- -- -- --
S&P BSE Healthcare TRI 50.93 1.19 2.53 3.95 5.15 30.95 49.55 -- -- -- --
Equity: Sectoral-Pharma 56.56 1.04 2.79 4.09 6.06 30.45 56.97 -- -- -- --
Rank within category 3 5 8 7 7 2 3 -- -- -- --
Number of funds in category 9 9 9 9 9 9 9 4 3 3 0

As on 26-Nov-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 59.54 -- -- 1.46 1,962
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 56.29 20.78 11.03 1.15 3,900
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 55.80 14.12 5.87 1.14 1,445
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 64.74 -- -- 0.68 1,036
DSP Healthcare Fund - Direct Plan  | Invest Online
Unrated
Nov-18 69.22 -- -- 0.81 890

Best & Worst Performance

Best (Period) Worst (Period)
Week 23.22 (01-Apr-2020 - 09-Apr-2020) -11.63 (11-Mar-2020 - 18-Mar-2020)
Month 35.24 (27-Mar-2020 - 27-Apr-2020) -20.44 (20-Feb-2020 - 23-Mar-2020)
Quarter 50.94 (23-Mar-2020 - 22-Jun-2020) -13.70 (23-Dec-2019 - 23-Mar-2020)
Year 79.34 (07-Oct-2019 - 06-Oct-2020) -10.86 (28-Aug-2018 - 28-Aug-2019)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 13.24 23.70 0.35 0.86 -- --
Equity: Sectoral-Pharma* 17.15 20.99 0.58 1.24 0.86 5.06
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Oct-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 30
Top 10 Stocks (%) 55.52
Top 5 Stocks (%) 35.52
Top 3 Sectors (%) 91.51
Portfolio P/B Ratio 2.78
Portfolio P/E Ratio 13.66

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 25,219 33,277
Giant (%) 10.63 8.95
Large (%) 38.40 46.55
Mid (%) 32.62 31.97
Small (%) 18.34 12.53
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Cipla Healthcare 32.34 12.21 7.98 9.54
up Sun Pharmaceutical Inds. Healthcare 83.47 10.43 9.02 9.35
up Alkem Laboratories Healthcare 23.00 6.86 0.00 6.86
equal Dr. Reddy's Lab Healthcare 50.62 9.83 1.47 5.00
equal Divi's Laboratories Healthcare 53.51 9.23 2.22 4.76
equal Tata Chemicals Chemicals 1.45 4.73 0.00 4.73
up Ipca Laboratories Healthcare 27.18 4.85 0.44 4.49
equal Lupin Healthcare -- 9.42 3.68 4.12
equal Cadila Healthcare Healthcare 25.54 9.43 3.10 3.52
up Sanofi India Healthcare 42.16 4.83 2.99 3.14
equal JB Chemicals & Pharma Healthcare 23.77 4.18 0.89 2.96
equal Indoco Remedies Healthcare 42.71 3.13 0.00 2.65
equal Biocon Healthcare 79.26 7.98 2.48 2.51
equal Torrent Pharmaceuticals Healthcare 37.02 5.00 1.92 2.49
up Fortis Healthcare (India) Healthcare -- 2.31 0.00 2.31
equal Natco Pharma Healthcare 31.28 3.87 0.00 2.26
equal Syngene International Healthcare 63.99 3.02 0.00 2.13
up Aster DM Healthcare Healthcare 37.25 2.28 0.18 2.00
equal Neuland Laboratories Healthcare 33.39 2.20 0.00 1.95
equal SBI Life Insurance Company Financial 52.83 6.04 1.84 1.84
equal Narayana Hrudayalaya Healthcare -- 3.11 0.12 1.81
down Dishman Carbogen Amcis Healthcare 25.00 3.82 1.07 1.68
equal Laurus Labs Healthcare 26.21 4.52 0.00 1.66
equal Gufic Biosciences Healthcare 35.71 1.35 0.00 1.35
equal Healthcare Global Enterprises Healthcare -- 1.11 0.00 0.84

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Oct-2020

Fund Manager

— Dharmesh Kakkad since 02-May-2020

Education: Mr. kakkad is B.com., CA & CFA.

Experience: Mr. Kakkad is Manager in ICICI Prudential Mutual Fund since 2009.

Funds Managed:


1.02%

Change from previous, NAV as on 26-Nov-2020

Growth: ₹ 16.8000

Dividend: ₹ 15.3900


Investment Strategy

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 100
Minimum No of Cheques 6
Minimum Withdrawal (₹) 1
Minimum Balance (₹) --
Exit Load 1% for redemption within 15 days

Basic Details

Fund House: ICICI Prudential Mutual Fund
Launch Date: 13-Jul-2018
Return Since Launch: 24.41%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 1,962 Cr (As on 31-Oct-2020)
Expense: 1.46% (As on 31-Oct-2020)
Risk Grade: --
Return Grade: --
Turnover: 42.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
Dividend05-Aug-20201.3000

Contact Information

AMC: ICICI Prudential Asset Management Company Ltd

Address: One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai - 400051

Phone: 022-26525000 / 1800-222-999 / 1800-200-6666

Fax: 022-26528100

Email: [email protected]

Website: http://www.icicipruamc.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

The key to financial well-being

dateFriday, 27-Nov-2020
time12:30 PM - 01:00 PM